Skip to main content
. 2021 Feb 15;18(1):105–119. doi: 10.20892/j.issn.2095-3941.2020.0098

Table 2.

Overall survival (OS) and disease-free survival (DFS) univariate analysis according to clinicopathological factors in 159 NSCLC patients

Variable No. of patients Percent (%) 6-Year OS rate (%) P 6-Year DFS rate (%) P
Gender
 Female 50 31.4 24.0 0.008 20.0 0.003
 Male 109 68.6 41.3 38.5
Age (years)
 < 60 72 45.3 38.9 0.414 36.1 0.558
 ≥ 60 87 54.7 33.3 29.9
Smoking status
 Never smoke 48 30.2 27.1 0.081 25.0 0.125
 Smoke 111 69.8 39.6 36.0
Type of resection
 Pneumonectomy 22 13.8 27.3 0.076 27.3 0.151
 Lobectomy 132 83.0 36.4 32.6
 Bronchial sleeve resection 5 3.1 60.0 60
Lesion
 Peripheral 111 69.8 35.1 0.503 32.4 0.415
 Central 48 30.2 37.5 33.3
Histologic subtyp
 Squamous cell carcinoma 102 64.2 37.3 0.886 34.3 0.871
 Adenocarcinoma 57 35.8 33.3 29.8
Location of tumor
 Left 65 40.9 33.8 0.420 27.7 0.203
 Right 94 59.1 37.2 36.2
Stage
 I 43 27.0 60.5 <0.001 53.5 <0.001
 II 52 32.7 44.2 40.4
 III 64 40.3 12.5 12.5
HBXIP expression
 Low 64 40.3 54.7 <0.001 51.6 <0.001
 High 95 59.7 23.2 20.0